Pfizer (Brazil) Today

PFIZ34 Stock  BRL 38.88  0.50  1.27%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Pfizer is trading at 38.88 as of the 4th of December 2024, a 1.27 percent decrease since the beginning of the trading day. The stock's open price was 39.38. Pfizer has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Pfizer Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2024 and ending today, the 4th of December 2024. Click here to learn more.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. PFIZER DRN operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 22.45 B outstanding shares. More on Pfizer Inc

Moving together with Pfizer Stock

  0.76LILY34 Eli LillyPairCorr
  0.68N1VS34 Novartis AGPairCorr
  0.61AMGN34 Amgen IncPairCorr

Moving against Pfizer Stock

  0.57UNIP5 Unipar CarbocloroPairCorr
  0.55GSGI34 Goldman SachsPairCorr
  0.54ARMT34 ArcelorMittal SAPairCorr
  0.53CTGP34 CitigroupPairCorr
  0.51BOAC34 Bank of AmericaPairCorr
  0.5UNIP3 Unipar CarbocloroPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Pfizer Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pfizer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
PresidentJohn Young
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
Pfizer Inc (PFIZ34) is traded on Sao Paulo Exchange in Brazil and employs 38 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.3 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pfizer Inc operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 22.45 B outstanding shares. Pfizer Inc has accumulated about 23.9 B in cash with 32.58 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07.
Check Pfizer Probability Of Bankruptcy

Pfizer Inc Risk Profiles

Although Pfizer's alpha and beta are two of the key measurements used to evaluate Pfizer's performance over the market, the standard measures of volatility play an important role as well.

Pfizer Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Pfizer Corporate Executives

Elected by the shareholders, the Pfizer's board of directors comprises two types of representatives: Pfizer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pfizer. The board's role is to monitor Pfizer's management team and ensure that shareholders' interests are well served. Pfizer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pfizer's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frank DAmelioCFO and Executive VP of Bus. OperationsProfile

Additional Information and Resources on Investing in Pfizer Stock

When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.